Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vitreous face is an anatomical term describing the interface or membrane at the anterior surface of the vitreous body (also known as the anterior hyaloid face). The vitreous body, which fills most of the eyeball, is a clear, gel-like structure composed primarily of water, collagen (type II and IX), and hyaluronic acid, and provides shape, clarity, and shock absorption for the eye[1][2][3][4]. The anterior hyaloid face is in direct contact with the lens and aqueous humor and helps separate the vitreous from the rest of the eye[2]. This structure is part of the eye's anatomy—not a molecule, receptor, or typical therapeutic target. The vitreous face is essential to ocular anatomy, particularly involved in the attachment between the vitreous gel and structures such as the retina and lens[2][4]. However, it does not possess pharmacological/biochemical activities itself and is not targeted by drugs. If seeking molecular targets relevant to vitreous biology or pathologies, consider components like collagen type II, hyaluronic acid, or enzymes involved in vitreous liquefaction and structure, but not the "vitreous face" itself. If your query intends to locate a molecular target in eye research, this entry is best considered a structural landmark; for pharmacological purposes, please search for specific proteins, enzymes, or receptors involved in vitreoretinal diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitreous face.